|
|
||||||||
The FASEB Journal, Vol 11, 775-783, Copyright © 1997 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
RA Miller, C Chrisp and A Galecki
Department of Pathology, Institute of Gerontology, Ann Arbor DVA Medical Center, University of Michigan 48109-0642, USA.
Aging leads to changes in the relative proportions of several functionally distinct T cell subsets, including increases in the proportions of memory cells in the CD4 and CD8 subsets and in the proportion of T cells expressing the multiple-drug resistance pump P- glycoprotein. To see whether individual differences in T cell subset levels predict life span, we measured the levels of five age-sensitive T cell subsets, at 8 and again at 18 months of age, in the peripheral blood of genetically heterogeneous mice bred as the progeny of CB6F1 females and C3D2F1 males. The strongest immunological predictor of life span in univariate regression analyses was the proportion of CD4 memory cells measured at 18 months of age (P=0.003). CD4 memory cell levels remained strongly correlated with life span (P<0.0003) in a multiple regression analysis after adjustment for sex. The proportion of CD4 cells expressing P-glycoprotein was also correlated with life span (P<0.01), but only in male mice. Weaker relationships were observed between life span and 8-month tests of CD8 memory and CD8 P- glycoprotein levels, for CD4 naive cells at 18 months, and for the change in CD4 naive cells between 8 and 18 months of age; these were, however, near the margin of statistical significance and could reflect chance relationships. The relationship between CD4 memory cell levels and life span was similarly strong regardless of the cause of death in mice whose death was attributable to lymphoma, fibrosarcoma, mammary carcinoma, and other forms of terminal pathology. Additional work is needed to discriminate between two hypotheses: 1) that high levels of CD4 memory cell themselves predispose to disease and early death, particularly from neoplasia; or 2) that accumulation of CD4 memory cells is a biomarker of some underlying process-perhaps accelerated aging-that itself leads to early mortality.
This article has been cited by other articles:
![]() |
C. Selman, S. Lingard, A. I. Choudhury, R. L. Batterham, M. Claret, M. Clements, F. Ramadani, K. Okkenhaug, E. Schuster, E. Blanc, et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice FASEB J, March 1, 2008; 22(3): 807 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar, J. C. Langer, and H.-W. Snoeck Transforming growth factor-beta2 is involved in quantitative genetic variation in thymic involution Blood, March 1, 2006; 107(5): 1974 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matejuk, C. Hopke, A. A. Vandenbark, P. D. Hurn, and H. Offner Middle-Age Male Mice Have Increased Severity of Experimental Autoimmune Encephalomyelitis and Are Unresponsive to Testosterone Therapy J. Immunol., February 15, 2005; 174(4): 2387 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Warner The Future of Aging Interventions: Current Status of Efforts to Measure and Modulate the Biological Rate of Aging J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2004; 59(7): B692 - B696. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Miller Biomarkers of Aging: Prediction of Longevity by Using Age-Sensitive T-Cell Subset Determinations in a Middle-Aged, Genetically Heterogeneous Mouse Population J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2001; 56(4): 180B - 186. [Abstract] [Full Text] |
||||
![]() |
A. U. Jackson, A. Fornés, A. Galecki, R. A. Miller, and D. T. Burke Multiple-Trait Quantitative Trait Loci Analysis Using a Large Mouse Sibship Genetics, February 1, 1999; 151(2): 785 - 795. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |